Sign In or Use Email

Jason Semprini, Ph.D.

Assistant Professor, Public Health at Des Moines University
From West Des Moines
I am an economist and a tenure-track assistant professor at Des Moines University. My research evaluates how public health policies impact our health and wellbeing. After completing my PhD, I trained in Cancer Epidemiology and Implementation Science as a postdoctoral scholar at the Iowa Cancer Registry. In 2023, I received my PhD in Health Services & Policy from the University of Iowa. In 2019, I earned my Master's in Public Policy at the University of Chicago as a Susan G. Komen Cancer Disparities Scholar. Before pursuing a career in academia, I served four years in Americorps and two years in the Peace Corps. My work is motivated by over a decade of professional and academic experience improving health outcomes in Iowa and beyond. I am especially motivated to understand how public health policies can reduce the growing burden of cancer in Rural America.
Merit logo.Follow Jason

Differences in definitive head and neck cancer treatment by hospital accreditation and Medicaid enrollment
Overall, 18 % of patients were enrolled in Medicaid at diagnosis, half of whom maintained continuous coverage for two years. Even after adjusting for other factors, Medicaid enrollees were 1.8 %-points more likely than non-enrollees to receive definitive care at a CoC-accredited hospital, with the largest advantage found in continuously enrolled patients (2.9 %-points). Regardless of hospital accreditation status, Medicaid enrollees were less likely to receive primary site surgery. This disparity was driven by those with discontinuous coverage. Finally, among patients receiving surgery, Medicaid enrollees at non-CoC hospitals were 3.4 %-points less likely to receive postoperative radiotherapy, with no differences among Medicaid enrollees at CoC-accredited hospitals. Continuous Medicaid enrollment and treatment at CoC-accredited hospitals appeared critical for HNC treatment, underscoring the importance of policies advancing continuity and standardization of care in pursuit of improving HNC care delivery in Medicaid funded cancer control systems.
April 2026 - Articles
Place-Based Disparities in Treatment and Time-to-Initiation for Head and Neck Cancer
Our sample included 70,468 HNC cases. We found no place-based differences for adjuvant or definitive treatment. Compared to patients in high-income counties, patients in low-income counties were 1.1% points less likely to receive surgery only (−2.2, −0.1) and 1.0% points more likely to receive radiation or chemotherapy alone (0.1, 1.8); and 2.1% points less likely to begin treatment within 0 to 29 days (−3.7, −0.4) and 1.4% points more likely to delay treatment until 60 to 89 days (0.5, 2.3). Our findings warrant implementing and evaluating system-level interventions to promote access to high-quality, timely HNC treatment in low-income communities.
March 2026 - Articles
Exploring rural-urban disparities in HPV vaccine initiation: new insights from the 2022 national health interview survey
As human papillomavirus (HPV)-associated cancers continue rising in rural America, identifying contributors to rural-urban gaps in HPV vaccination could inform public health priorities and targeted interventions. Analyzing nationally representative data from the 2022 National Health Interview Survey (NHIS), we evaluated rural-urban differences in HPV vaccination among individuals aged 9–29 years (all of whom were recommended to receive the HPV vaccine during adolescence since 2006). Generalized structural equation models adjusted for complex survey design, sociodemographic factors, and other vaccine utilization. Even after adjusting for other vaccine utilization, rural participants were 5.4%-points (CI = −9.7, −1.0) less likely to receive the HPV vaccine than urban participants. Rural-urban disparities in HPV vaccination varied by healthcare access barriers and geography, with the largest gap found in participants who were privately insured. Our work suggests that rural-urban disparities in HPV vaccination are driven by factors distinct from those associated with other vaccines and healthcare access.
February 2026 - Articles
Lung cancer incidence in counties at low and high risk of Radon Exposure: A Population-Based SEER analysis (1975–2022)
Compared to low-risk counties, counties at high risk of radon exposure had a significantly higher overall lung cancer incidence: 13.5 + cases per 100,000 person-years (95% CI: 10.0, 17.1). This gap between low and high-risk counties was largest for Adenocarcinoma and small cell carcinoma, and larger in males than females. However, only in females did we observe the gap in lung cancer incidence between low- and high-risk counties grow decade after decade.
February 2026 - Articles
Exploring the link between nitrate exposure and thyroid cancer: A nationwide state-level analysis
For the 0 to 14 or 40 to 59 age groups, we found no differences in thyroid cancer incidence by nitrate exposure. For ages 15 to 39, there were 41.6 (CI: 6.2, 77.1) more cases in high nitrate states, reflecting an 18.5% difference. Stratified by sex, in the 15 to 39 age group of females had 32.7 (CI: 6.3, 59.1) more cases and males had 8.2 (CI: 0.1, 16.4) more cases, reflecting a 17.8% and 20.4% difference respectively.
January 2026 - Articles
Nitrate and Brain/CNS Cancer Diagnoses in the First Year of Life
Nitrates in drinking water, common in agricultural states like Iowa, pose health risks to young infants. This brief first reviews the plausible biological mechanisms linking nitrate exposure to brain and central nervous system (BCNS) cancers in the first year of life. We then linked historic water quality and cancer registry data at the county level to construct linear and quantile regression models estimating the association between a BCNS diagnosis and nitrate measures. We found significantly higher nitrate levels preceding pediatric zero-year-old BCNS cancer diagnoses. These findings support investigating early-life nitrate exposure as a potential risk factor for infant BCNS tumors.
December 2025 - Articles
A survey of cancer affiliate network hubs in the US: goals, composition, resources, and evaluation
We found that cancer affiliate networks generally aimed to improve access and delivery of high-quality cancer care, with considerable variation in the activities used to achieve and evaluate progress toward these goals. As networks continue to operate and emerge, research is needed to identify best practices for optimizing networks’ influence on the quality of care in resource-constrained hospitals and enabling effective scaling of the cancer affiliate network model.
September 2025 - Articles
Evaluating intersectional variation of HPV-associated cancers in rural America
Between 2010 and 2019, rural HPV-associated cancer was 11.8 cases per 100,000 population. We found significant heterogeneity within male (10.5) and female (13.2) rates. For males, the lowest rate was found in non-Hispanic Asian-American/Pacific-Islander populations (3.7) and Hispanic populations (4.8), and the highest rate was found in non-Hispanic White populations (11.2). For females, the lowest rate was also found in Hispanic Asian-American/Pacific-Islander populations (8.8) and the highest rates were found in non-Hispanic Black (13.8) and non-Hispanic American Indian/Alaska Native populations (14.5). However, these racial/ethnic differences varied across rural subpopulations, geography, and poverty. Appreciating the diversity of the rural cancer burden can be used to effectively develop and implement public health interventions to address HPV-related cancer disparities in rural communities. Actions are needed to prioritize reducing the burden of HPV-associated cancer in AIAN populations in high-poverty rural communities.
August 2025 - Articles
Metropolitan/nonmetropolitan differences of the impact of COVID-19 on cancer survivors' care
Survivors in nonmetropolitan compared to metropolitan areas had less perceived change in cancer follow-up and treatment schedules. It will be important to assess whether shifts in follow-up and preventive care to telehealth for cancer survivors in need of care during the COVID-19 pandemic affect their long-term outcomes.
July 2025 - Articles
Diverging trends of HPV-associated cancer in metro/non-metro counties
Our study reaffirmed the persistent, diverging incidence of HPV-associated cancer in non-metro America. Prioritizing effective risk reduction policies should be considered especially urgent in states with the > 3% annual growth in non-metro HPV-associated cancer incidence (Illinois, Iowa, Kentucky, Louisiana, Texas). We predict that the divergence in rates and rising trends in non-metro regions are due to stagnate declines in smoking rates and lower adherence to recommended preventative measures.
July 2025 - Articles
State Cigarette Taxes and Lung Cancer Incidence, United States, 1970-2019
Although smoking is the leading cause of lung cancer, smoking rates have been declining for decades, in part due to increasing cigarette taxes. This study analyzed how states increased and responded to cigarette taxes to determine whether increasing contemporary cigarette taxes could reduce lung cancer incidence in the United States. Centers for Disease Control and Prevention data were used to measure state-level cigarette tax and consumption (pack sales per capita). For each state, the elasticity of demand (change in cigarette consumption percentage/change in state tax) was estimated. Then, each state was classified into 4 mutually exclusive groups based on median change in the state cigarette tax from 1970 to 2019 (high, low) and median elasticity (high, low). Finally, state-level, sex-stratified data from the North American Association of Centralized Cancer Registries (2000-2019) were analyzed to test whether the incidence of small cell and squamous cell lung cancer varied by group. From 1970 to 2019, cigarette tax increases ranged from $0.08 (Missouri) to $4.90 (District of Columbia). The median tax increase was $1.54. The elasticity of demand for cigarettes from state taxes ranged from −0.10 (West Virginia) to −0.64 (Georgia). The median elasticity was −0.40. Among males, the low-elasticity, low–tax change group had the highest incidence of small cell and squamous cell lung cancer. No significant differences in incidence were found across groups among females. Increasing cigarette taxes could reduce the future incidence of lung cancer among males. Other social or environmental policies, however, may be necessary to reduce lung cancer incidence among females.
July 2025 - Publications
Early prenatal nitrate exposure and birth outcomes: A study of Iowa’s public drinking water (1970–1988)
Rising levels of nitrate in our drinking water pose a threat to public health. Emerging evidence suggests a possible association between early prenatal exposure to nitrate in drinking water and adverse birth outcomes. Understanding this association has proved challenging, as there is currently no regulatory guidance on safe levels of nitrate during the early prenatal period and many factors contribute to adverse birth outcomes. Focusing on Iowa, a state with some of the highest levels of ground water nitrate in the country, this study linked public water quality data to more than 350,000 birth records. During the study period (1970–1988), nitrate levels increased 8% annually. Mean nitrate levels were 4.2 mg/L, well below the 10 mg/L regulatory threshold. Interestingly, exposure to nitrate above the 10 mg/L threshold had no association with birth outcomes. Rather, the study showed that prenatal exposure to lower levels of nitrate were adversely associated with gestational age and low birthweight. These results suggest that current regulatory standards, which have not been updated since 1992, may be inadequate.
June 2025 - Articles
Hospital Accreditation and Geographic Disparities in Timely Cancer Care
Treatment at an accredited hospital appeared to increase time-to-treatment differences between high-and low-income counties and low-income counties. This heterogeneity may reflect access challenges facing low-income cancer patients. Health systems seeking to provide high quality, timely care must overcome these access challenges as they navigate patients through the cancer care continuum. While a 2.6-day delay in treatment may not impact outcomes, future research should understand why patients from lower-resource communities wait longer than patients in affluent communities.
June 2025 - Articles
Quantifying the impact of introducing HPV vaccines in 2006 on 25-29-year-old cervical cancer incidence in 2022
We found that, unlike the stagnate trends in older females between 2019 to 2022, in 25-29-year-old females, cervical cancer incidence declined 2.1 cases/100,000 (CI = -2.7, -1.6): a 48% reduction from baseline trends. Although tempered by uneven adherence, after fifteen years we finally appear to be realizing quantifiable benefits from this cancer prevention vaccine.
June 2025 - Articles
Quantifying the burden of cancer in Puerto Rico’s oldest residents
We analyzed Puerto Rico cancer incidence and mortality rate data for male and female residents aged 85+. Since 2001, for both males and females aged 85 + in Puerto Rico, cancer incidence and mortality rates declined as the proportion of distant stage cancers increased.
May 2025 - Articles
Preventing HPV Cancers with Rural Communities: Updates and Opportunities
St. Jude's Children's Hospital presents progress on priority action items and showcases successful efforts to promote HPV cancer prevention with rural communities.
May 2025 - Presentations
Early Prenatal Nitrate Exposure and Birth Outcomes: A Study of Iowa’s Public Drinking Water (1970-1988)
Presentation at annual Public Health in Iowa Conference. The 60-minute presentation to 55+ public health professionals showed evidence that exposure to nitrate levels below the regulatory threshold are associated with adverse birth outcomes.
April 2025 - Presentations
The inclusion of tribes and American Indian and Alaska Native People in State comprehensive cancer control plans
Cancer Causes & Control - By highlighting state and Tribal CCC plans’ best practices and incorporating Tribal priorities within state and district CCC plans and programs, we underscore the importance of addressing cancer in Tribal populations across the U.S. and offer examples of inclusive CCC plan development and implementation.
March 2025 - Publications
The Affordable Care Act and change in human papillomavirus (HPV) vaccine uptake in the United States
Vaccine - The ACA has been associated with increased HPV vaccination uptake, especially among racial/ethnic minorities, gains likely driven by an increase in vaccination-enabling factors such as decreased uninsurance and increased access to physician visits.
March 2025 - Publications
Harvesting Best Practices to Prevent Rural HPV Cancers
Rural life is a choice made by 1 in 5 people, but they do not choose to be at higher risk of cancers, including HPV cancers. HPV vaccination is cancer prevention. This virtual seminar will explore progress to prevent HPV cancers with rural communities in the U.S.
March 2025 - Presentations
2025 Rural HPV Vaccination Learning Community Series
The American Cancer Society (ACS) and The National HPV Vaccination Roundtable (HPVRT) are partnering with rural healthcare partners to expand knowledge and increase on-time HPV vaccination.
March 2025 - Presentations
The Affordable Care Act and Change in Human Papillomavirus (HPV) Vaccine Uptake in the United States
The ACA has been associated with increased HPV vaccination uptake, especially among racial/ethnic minorities, gains likely driven by an increase in vaccination-enabling factors such as decreased uninsurance and increased access to physician visits.
March 2025 - Publications
Socioeconomic and Geographic Differences in Mammography Trends Following the 2009 USPSTF Policy Update
JAMA Network Open - Did female biennial mammography screening rates change after the US Preventive Services Task Force (USPSTF) 2009 policy update? This cross-sectional study of 1.6 million females found reduced mammography rates after the USPSTF 2009 update for those no longer recommended to complete a biennial mammogram. These decreases varied by age, race and ethnicity, binge drinking status, and state of residence. The findings of this study suggest that patient-level variables related to breast cancer risk are associated with differences in how women responded to the 2009 USPSTF mammography guidance.
February 2025 - Publications
In Reference to Effect of Rurality in Head and Neck Cancer: A Scoping Review
The Laryngoscope - The recent scoping review by Tomescu et al. on the effects of rurality on head and neck cancer brings a helpful focus to an important topic. There are many disparate effects of rurality on treatment and outcomes that must be better studied in a targeted manner.
February 2025 - Articles
What cancers explain the growing rural-urban gap in human papillomavirus-associated cancer incidence?
Journal of Rural Health - Although preventable, nonmetropolitan Americans have shouldered a growing burden of HPV-associated cancers. To address these cervical, anal, and oropharyngeal cancer disparities, it is imperative that HPV vaccination programs are effectively implemented at scale.
January 2025 - Publications
Declining Incidence of Childhood Cancers: An Updated Analysis of the National Childhood Cancer Registry Data (2018–2021)
Pediatric Blood & Cancer - Despite the pandemic’s impact on adult cancer prevention and control, there appears to have been minimal impact on cancer surveillance in common pediatric cancers within pediatric populations. We may have reason to be hopeful given the persistent declining incidence of pediatric cancer in the U.S. since 2018. The trends in the AYA population also appear quite steady, especially relative to the adult cancers. Although we still observe some differences related to the accreditation status and the magnitude of declining trends in pediatric and AYA cancer incidence, we still have no explanation as to why. Whether these differences are a result of surveillance, data issues, or access differences warrants further investigation.
January 2025 - Publications
Head and neck cancer treatment delays in 2021: Estimating distributional effects by site, surgery, and p16-positivity
Oral Oncology Reports - HNC patients overall, but HPV+ Oropharynx cancer patients especially, experienced treatment delays in 2021. These delays, and their consequences, warrant policymaking attention.
December 2024 - Publications
Registered Report Stage 2: How Did the COVID-19 Pandemic Change Cigarette Smoking Behavior?
Lifestyle Medicine - Smoking prevalence continues to decline in the United States, and the pandemic appeared to have been associated with lower smoking rates. However, our results suggest that the pandemic was also associated with greater intensity and fewer quit attempts among smokers warranting greater attention from policymakers and researchers.
November 2024 - Publications
Evaluating machine learning model bias and racial disparities in non-small cell lung cancer using SEER registry data
Healthcare Management Science - NSCLC disparities are complex and multifaceted. Yet, even when accounting for age and stage at diagnosis, non-Hispanic Black patients with NSCLC are less often recommended to have surgery than non-Hispanic White patients. Machine learning models amplified the racial/ethnic disparities across the cancer care continuum (which are reflected in the data used to make model decisions). Excluding race/ethnicity lowered the bias of the models but did not affect disparate impact. Developing analytical strategies to improve fairness would in turn improve the utility of machine learning approaches analyzing population-based cancer data.
November 2024 - Publications
RE: A population-based study of COVID-19 mortality risk in US cancer patients
JNCI - In this issue of the Journal, Mani et al. reminded us of the elevated risk from COVID-19 facing people living with cancer. Analyzing population-based data, the authors showed that people with cancer have a 2.3 times higher mortality from COVID-19 than the rest of the US population. The authors also compared relative mortality from COVID-19 across age groups, sex, race and ethnicity, and other factors. We worry, however, that these comparisons may underestimate the death toll we witnessed during 2020.
November 2024 - Articles
Racial Disparities in Cancer Guideline-Concordant Treatment Using Surveillance, Epidemiology, and End Results Data for Patients With NSCLC
JTO Clinical & Research Reports - Receiving GCIT considerably improves survival across all races, though disparities in receipt are observed. Interventions are needed to ensure equitable access to guideline-concordant care and reduce survival disparities for patients.
October 2024 - Publications
Understanding the 2020 pediatric cancer deficit: Insights from the National Childhood Cancer Registry
Pediatric Blood & Cancer - We explore whether the COVID-19 pandemic disrupted trends of common pediatric and AYA cancers.
October 2024 - Publications
The burden of HPV-associated cancer in rural America beyond 2020
Rural & Remote Health - HPV-associated cancer can be prevented by a vaccine. However, HPV vaccination rates are lower in non-metro than metro counties. Again, however, there is likely variation within non-metro counties. Given low historical adherence to HPV-vaccine schedules and the negative trends in this current study, I predict that the rising rural burden of HPV-associated cancer will intensify in the coming decade without effective prevention and control strategies in rural America.
October 2024 - Publications
Colorectal cancer in older adults after the USPSTF’s 2008 updated screening recommendation
Cancer Epidemiology - The USPSTF’s 2008 recommendation was associated with reduced colonoscopies, especially in adults over age 85. Whether this recommendation, or the 2021 updated guidance, optimizes population health by reducing the burden of CRC screening in older adults remains unknown.
September 2024 - Publications
Sex & marital differences in delayed pharyngeal cancer treatment before and after medicaid expansion
Oral Oncology Reports - Given the importance of timely pharyngeal cancer treatment, health systems must identify and address the drivers of treatment delays to advance cancer equity.
September 2024 - Publications
Vaping could reduce harm caused by smoking
The Gazette - Letter to the editor.
September 2024 - Others
Leveraging public health cancer surveillance capacity to develop and support a rural cancer network
Learning Health Systems - As rural hospitals continue to face resource constraints, multisectoral efforts informed by data from centralized public health surveillance systems can promote quality improvement initiatives across rural communities. While our work remains preliminary, we predict that analytic support provided by the Iowa Cancer Registry will enable the rural network hospitals to focus their capacity toward developing the infrastructure necessary to deliver high-quality care and serve the unique needs of rural cancer patients.
August 2024 - Publications
Preventing HPV Cancers with Rural Communities
St. Jude’s Children's Hospital HPV Cancer Prevention Program - Quarterly Meeting
August 2024 - Presentations
DMU Student and Professor Published in Pediatric Journal

Des Moines University Medicine and Health Sciences student Arshi Sajid, DO'28, along with Jason Semprini, PhD, assistant professor of public health, published a paper titled "Nitrate and Brain/CNS ...

January, 28 2026 - Verified by Des Moines University
DMU Professor Selected as National Research Champion

Jason Semprini, Ph.D., MPP, assistant professor of public health at Des Moines University Medicine and Health Sciences, was named to the inaugural cohort of AcademyHealth's Champions for Health Services and Prevention Research program. Supported by the...

November, 19 2025 - Verified by Des Moines University
© Copyright 2026 • Merit Pages, Inc.Terms of ServicePrivacy Policy